(R)-4-((R)-1-(3-(difluoromethyl)-6-(3,4-dimethoxyphenyl)-3H-imidazo[4,5-c]pyridin-4-yloxy)ethyl)-1-((R)-1-(4-methoxyphenyl)ethyl)pyrrolidin-2-one → (R)-4-((R)-1-(3-(difluoromethyl)-6-(3,4-dimethoxyphenyl)-3H-imidazo[4,5-c]pyridin-4-yloxy)ethyl)pyrrolidin-2-one
Reaction equation
[F:1][CH:2]([F:41])[N:3]1[C:7]2[C:8]([O:22][C@@H:23]([C@H:25]3[CH2:29][N:28]([C@@H](C4C=CC(OC)=CC=4)C)[C:27](=[O:40])[CH2:26]3)[CH3:24])=[N:9][C:10]([C:12]3[CH:17]=[CH:16][C:15]([O:18][CH3:19])=[C:14]([O:20][CH3:21])[CH:13]=3)=[CH:11][C:6]=2[N:5]=[CH:4]1>C(O)(C(F)(F)F)=O>[F:41][CH:2]([F:1])[N:3]1[C:7]2[C:8]([O:22][C@@H:23]([C@H:25]3[CH2:29][NH:28][C:27](=[O:40])[CH2:26]3)[CH3:24])=[N:9][C:10]([C:12]3[CH:17]=[CH:16][C:15]([O:18][CH3:19])=[C:14]([O:20][CH3:21])[CH:13]=3)=[CH:11][C:6]=2[N:5]=[CH:4]1Participants
3
Reactant 1
Product 1
Reagents, catalysts & solvents 1
Conditions
- Temperature
- 60 °C
Procedure
(R)-4-((R)-1-(3-(difluoromethyl)-6-(3,4-dimethoxyphenyl)-3H-imidazo[4,5-c]pyridin-4-yloxy)ethyl)-1-((R)-1-(4-methoxyphenyl)ethyl)pyrrolidin-2-one 2.30 (max. 0.153 mmol) was dissolved in TFA (2 mL) and heated to 60° C. with stirring. After 22 h, the red solution was concentrated in vacuo and diluted with EtOAc (20 mL) and saturated aqueous NaHCO3 (20 mL). The phases were separated and the aqueous phase was extracted with EtOAc (20 mL). The combined organic phase was dried over Na2SO4, filtered, and concentrated onto 2 g silica gel. Purification by silica gel chromatography (0% to 2.5% to 5% MeOH in DCM) provided (R)-4-((R)-1-(3-(difluoromethyl)-6-(3,4-dimethoxyphenyl)-3H-imidazo[4,5-c]pyridin-4-yloxy)ethyl)pyrrolidin-2-one 3.02.
Workup
- concentrationthe red solution was concentrated in vacuo
- additiondiluted with EtOAc (20 mL) and saturated aqueous NaHCO3 (20 mL)
- customThe phases were separated
- extractionthe aqueous phase was extracted with EtOAc (20 mL)
- dry with materialThe combined organic phase was dried over Na2SO4
- filtrationfiltered
- concentrationconcentrated onto 2 g silica gel
- customPurification by silica gel chromatography (0% to 2.5% to 5% MeOH in DCM)
Sources & evidence
- ORD record
- ord-830cbdbe8d5a44aca1ae03fb36c662d1
- Source dataset
- uspto-grants-2016_06
- Patent number
- US09376441B2
Reaction notes
Loading…